Home LiteratureArticle Details

PMID: 14966109 Published · ppublish English Letter Meta-Analysis Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 22 ·No. 4 ·2004-02-15 ·Pages 756-8

Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T

Abstract

暂无摘要

MeSH Terms

Activin Receptors, Type I/genetics Female Gene Frequency Genetic Predisposition to Disease Humans Molecular Epidemiology Neoplasms/epidemiology,genetics Protein Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type I Receptors, Transforming Growth Factor beta/genetics

Chemicals

Receptors, Transforming Growth Factor beta Protein Serine-Threonine Kinases Activin Receptors, Type I Receptor, Transforming Growth Factor-beta Type I TGFBR1 protein, human

Authors & Affiliations

11 authors, click to expand affiliations / ORCID

Pasche Boris

Kaklamani Virginia

Hou Nanjiang

Young Taya

Rademaker Alfred

Peterlongo Paolo

Ellis Nathan

Offit Kenneth

Caldes Trinidad

Reiss Michael

Zheng Tongzhang

Article Info

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abbr.

J Clin Oncol

ISSN

0732-183X

DOI

10.1200/JCO.2004.99.271

Published

2004-02-15

Pages

756-8

Language

English

Region

United States

NLM ID

8309333

Subset

Grants

NCI NIH HHS · CA89018 · United States

NCI NIH HHS · CA90386 · United States

External Links

PubMed source DOI: 10.1200/JCO.2004.99.271 View journal details

Analysis Services

TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.

Contact

WeChat Official Account